We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Issues Final Guidances on Postmarket Surveillance and Postapproval Studies
FDA Issues Final Guidances on Postmarket Surveillance and Postapproval Studies
The FDA offers advice on postmarket surveillance and postapproval studies for moderate and high-risk devices in two final guidance documents released yesterday.